earnings
confidence high
sentiment positive
materiality 0.80
RxSight Q2 revenue $11.4M (+132% YoY); raises FY22 guidance to $44-46M
RxSight, Inc.
2022-Q2 EPS reported
-$1.25
revenue$20,301,000
- Revenue $11.4M (+132% YoY); sold 49 LDDs, installed base 294 (+126% YoY).
- LAL procedure volumes 5,400 (+196% YoY).
- Net loss $(16.7)M ($0.61/share); adjusted loss $(13.8)M ($0.50/share).
- Raised FY22 revenue guidance to $44-46M (95-104% growth); gross margin guidance to 37-38%.
- Cash and investments $128.6M; long-term debt $39.9M.